Home » Topics » Regulatory

Regulatory
RSS

Neurontin receives FDA approval for postherpetic neuralgia

June 3, 2002

Abreva approved for OTC sale in Canada, Korea

June 3, 2002

Ethypharm and Aventis collaborate to create Flash version of Allegra

May 29, 2002

Eligard 7.5 mg launched for advanced prostate cancer

May 29, 2002

MicardisPlus approved in E.U. for hypertension

May 28, 2002

New indication and low dose strength of Vivelle-Dot approved

May 27, 2002

Copaxone prefilled syringes launched in Canada

May 27, 2002

MitoExtra NDA amendment accepted for filing

May 27, 2002

New strengths of Adderall XR approved for ADHD

May 27, 2002

Zelapar NDA in Parkinson's disease accepted for filing

May 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...